
Share on:
ORTHOWORLD estimates that the global orthopedic market will grow 5% in 2024 to $62 billion, with the companies above accounting for nearly 70% of worldwide sales. They enter 2025 with various level of optimism for increased sales revenue and product innovation.
- Stryker is flourishing in a robust market that its leadership believes is the new normal for orthopedics.
- Johnson & Johnson MedTech hopes an evolving technology portfolio generate some positive momentum.
- Zimmer Biomet has a chance to differentiate itself through its expanding technology ecosystem.
- Smith+Nephew’s recon business saw positive growth due to better supply and commercial execution and the continued adoption of the CORI robotic system.
- Medtronic is betting that its AiBLE digital ecosystem will continue to fuel the company’s success in spine.
- Arthrex wants to integrate its visualization cameras and endoscopes into the advancement of endoscopic spine surgery.
- Globus Medical sees a slightly higher ceiling for spine market growth over the long-term.
- Enovis believes it has a foot and ankle pipeline that can drive double-digit growth.
It will be interesting to watch the performance of these companies as the year progresses and the orthopedic market continues its single-digit growth.
The infographic is proudly sponsored by Intech, your premier vertically integrated design and manufacturing partner dedicated to orthopedics.
RELATED ARTICLES
4D Medicine to Showcase Breakthrough Biomaterials at OMTEC 2025
Jun 06 2025 , Julie A. Vetalice
Placon Announces New Costa Rica Warehouse and Distribution Facility
Jun 02 2025 , Julie A. Vetalice
On a Mission to Create Equity in Worldwide Orthopedic Care
May 28 2025 , BONEZONE Editors